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LETTERS
Previous studies showed that 
pandemic (H1N1) 2009 may have 
become established in swine 
populations in Canada, Norway, and 
Hong Kong (1,5–8). The human-
to-pig transmission of pandemic 
(H1N1) 2009 may substantially 
affect virus evolution and subsequent 
epidemiology. Although the pandemic 
was mild, the virus could develop 
further reassortment in swine and gain 
virulence. On the other hand, subtype 
H5N1 and H9N2 viruses have become 
established in pigs, so the introduction 
of pandemic (H1N1) 2009 virus to 
pigs has provided the possibility for 
the incorporation of avian virus genes 
into mammalian-adapted viruses. 
That transmission could occur from 
humans to pigs and vice versa is 
especially troublesome. Given the 
possible production of novel viruses 
of potential threat to public health, 
we should emphasize infl uenza 
surveillance in pigs and establishment 
of the genetic basis of the viral 
genome for rapidly identifying such 
reassortment events.
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Pulmonary Disease 
Associated with 
Nontuberculous 
Mycobacteria, 
Oregon, USA
To the Editor: Nontuberculous 
mycobacteria (NTM) are environ-
mental organisms ubiquitous in 
soil and water, including municipal 
water supplies. When inhaled, these 
organisms cause chronic, severe 
lung disease in susceptible persons 
(1). Recent epidemiologic studies 
suggest NTM pulmonary disease 
is increasingly prevalent in North 
America, with annual incidence rates 
of 13 cases per 100,000 population 
in persons >50 years of age and 
2–4-fold higher in older age groups 
(2–4). The current distribution of 
pulmonary NTM disease has been 
poorly characterized with regard 
to environment, climate, and other 
factors.
We recently performed a 
statewide NTM surveillance project 
in Oregon, United States, where we 
documented higher pulmonary disease 
rates within the moister, temperate 
western regions of the state. Oregon 
is bisected north-south by mountains 
into 2 distinct climate zones. Western 
Oregon, where 87% of the state’s 
population lives, is temperate and 
wet; eastern Oregon is primarily rural, 
with an arid, high desert climate. Our 
goal was to evaluate whether disease 
clustering within the state could be 
explained by population density.
For all Oregon residents who 
had newly diagnosed and existing 
pulmonary NTM disease during 2005 
and 2006, we used case-patient home 
ZIP code and county of residence to 
construct statewide disease maps 
(4). We obtained state ZIP code and 
county-level census data for 2005 
and 2006 from the Portland State 
University Population Research 
Center and used Oregon Offi ce of 
Rural Health criteria to designate 
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ZIP codes as urban or rural and 
counties as rural (nonmetropolitan), 
micropolitan, or metropolitan (5,6). 
Unlike ZIP code data, which lacked 
age information, county census data 
were age stratifi ed and consisted of 
population numbers aggregated in 
5-year age groups (e.g., 0–4 years, 5–9 
years). Because nearly all pulmonary 
NTM disease occurred in persons 
>50 years of age, we calculated age-
adjusted disease prevalence rates (by 
using 95% Poisson exact confi dence 
intervals) for patients >50 years of age 
in the county census data. We used the 
Cochran-Armitage test for trend to 
evaluate differences in rates by rural, 
micropolitan, and metropolitan county 
designations.
Statewide, 385 (94%) of 
411 NTM cases occurred among 
residents of western Oregon, and 
the crude rate of annual disease 
prevalence was signifi cantly higher 
in western than in eastern Oregon 
(6.0 vs. 2.7/100,000; p<0.05) (online 
Appendix Figure, www.cdc.gov/
EID/content/17/9/101929-appF.htm). 
Within the western region, rates were 
signifi cantly higher in urban than in 
rural ZIP codes. Using county-level 
data, we found that age-adjusted 
prevalence rates in western Oregon 
strongly correlated with increasing 
levels of population density (Table). 
In eastern Oregon, where only 26 
cases occurred, age-adjusted rates 
among residents >50 years of age 
were similar (7.6 cases/100,000 
population) to those in rural counties 
within western Oregon (6.5/100,000).
In Oregon, where most 
pulmonary NTM disease is caused 
by Mycobacterium avium complex 
(MAC), our fi ndings suggest that 
the higher rates of disease in the wet 
western portion of the state are best 
explained by differences in population 
density (4). Disease rates there were 
highly correlated with increasing 
population density, and in rural areas 
of western Oregon, disease rates were 
similar to those in the arid, primarily 
rural eastern portion of the state.
Humans presumably are exposed 
to NTM daily through showering, 
bathing, and other activities where 
water or soil is aerosolized (7). 
Previous environmental studies 
suggest that persons living in urban 
areas could potentially have greater 
NTM exposure during these activities 
because NTM is more prevalent in 
piped networks of municipal water 
systems than in well-water systems 
primarily used in rural regions (8). 
A study in Japan in the 1980s found 
a similar association of pulmonary 
NTM disease (primarily MAC) with 
urban and wet environments compared 
with arid and rural regions in our 
study but unlike our study was not 
able to evaluate differences in disease 
rates between urban and rural areas 
independent of climate differences 
(9). A 1979 Texas study found an 
association of pulmonary NTM with 
rural living, although this result was 
driven by M. kansasii disease, and 
rates of MAC were actually higher 
in rural areas (10). These and other 
similar studies were conducted 
decades ago when the epidemiology 
of NTM was substantially different 
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Table. Prevalence of pulmonary nontuberculous mycobacterial disease, by geographic region and population density, Oregon, USA, 
2005 and 2006* 
Region/population density 
Prevalence† (95% confidence interval) 
Total no. cases All age groups Age <50 y Age >50 y 
Total 411 5.6 (5.0–6.1) 1.1 (0.8–1.4) 15.2 (13.6–16.9) 
County-level analysis 
 Western 385 6.0 (5.4–6.6) 1.2 (0.9–1.6) 16.5 (14.8–18.4) 
  Metropolitan 341 6.3 (5.7–7.0) 1.3 (1.0–1.8)‡ 18.0 (16.0–20.2)§¶# 
  Micropolitan 39 4.5 (3.2–6.1) 0.2 (0.0–1.0)‡ 11.1 (7.8–15.2)§¶ 
  Rural 5 3.6 (1.2–8.3) 1.3 (0.0–7.1) 6.5 (1.8–15.9)§# 
 Eastern 26 2.7 (1.8–4.0) 0.2 (0.0–0.9) 7.6 (4.9–11.2) 
  Metropolitan 9 3.0 (1.4–5.6) 0.0 (0.0–1.8) 8.6 (3.9–16.3) 
  Micropolitan 12 2.5 (1.3–4.3) 0.3 (0.0–1.7) 6.8 (3.4–12.2) 
  Rural 5 2.9 (1.0–6.8) 0.0 (0.0–3.5) 7.8 (2.5–18.2) 
ZIP code** 
 Western 365 5.7 (5.2–6.4) – –
  Urban 277 6.4 (5.7–7.2)†† – –
  Rural 88 4.3 (3.5–5.3)†† – –
 Eastern 26 2.8 (1.8–4.0) – –
  Urban 5 2.7 (0.9–5.7) – –
  Rural 21 2.8 (1.7–4.1) – –
*Annualized 2-year disease period prevalence, Oregon, 2005 and 2006. 
†Cases per 100,000 population. 
‡Significant differences (p<0.05) between western Oregon metropolitan and micropolitan counties, age <50 y. 
§West, age >50 y, metropolitan, micropolitan, and rural (Cochran-Armitage test for trend, p<0.01). 
¶Significant differences (p<0.05) between western Oregon metropolitan and micropolitan counties, age >50 y. 
#Significant differences (p<0.05) between western Oregon metropolitan and rural counties, age >50 y. 
**Included only the 391 patients for whom with ZIP code data were available. –, age-level data not available for ZIP codes. 
††Significant differences (p<0.05) between western Oregon urban and rural ZIP codes. 
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(i.e., predominantly a disease of male 
patients) and before the formulation of 
the 2007 American Thoracic Society/
Infectious Diseases Society of America 
pulmonary NTM disease criteria (1).
We were limited in drawing fi rm 
conclusions about why pulmonary 
NTM is more common in urban 
areas because we were not able to 
evaluate patients or regional water 
systems within our study. Persons 
living rurally might be less likely to 
seek medical care and thus have NTM 
diagnosed, which would account for 
the differences in our study. However, 
given the reasonably close proximity 
of western Oregon’s rural regions to 
major medical centers, we believe this 
scenario is unlikely.
Our fi ndings suggest that pul-
monary NTM disease is closely 
associated with urban living. We 
suspect the difference in disease rates 
between urban and rural areas might 
refl ect differences in host exposure 
to these pathogens. Further studies 
should be undertaken to elucidate the 
environmental exposures associated 
with pulmonary NTM.
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Carriage of 
Meningococci by 
University 
Students, United 
Kingdom
To the Editor: Neisseria 
meningitidis causes septicemia and 
meningitis (1). Meningococci usually 
persist on the nasopharyngeal mucosa 
of asymptomatic carriers (2). Because 
carriers are the only reservoir of 
meningococci, carriage in at-risk 
populations should be monitored. 
Meningococcal carriage rates have 
been assessed during 1997–8 for 
fi rst-year students at the University 
of Nottingham (3) and in autumn 
during 1999–2001 for >48,000 sixth-
form students (pre-university, age 
range 15–17 years) throughout the 
United Kingdom (4). Serogroup B and 
nongroupable strains predominated; 
serogroup Y strains were found in 
only 1%–2% of participants. 
From November 2008 through 
May 2009, to investigate persistence 
and spread of meningococcal strains 
in students living in dormitories, we 
conducted a longitudinal study in a 
cohort of 190 fi rst-year students at the 
University of Nottingham. We found 
high rates of carriage and prevalence 
of serogroup Y strains (5). 
During September 2009 (fi rst 
week of term) through March 2010, 
we conducted a large repeated cross-
sectional study analyzing pharyngeal 
swabs from students in all school-
year groups at Nottingham University. 
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